Terms: = Ovarian germ cell tumor AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
162 results:
1. Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors.
Summey RM; Gornstein E; Decker B; Dougherty KC; Rader JS; Hopp E
Cancer Med; 2024 Jun; 13(12):e7340. PubMed ID: 38898688
[TBL] [Abstract] [Full Text] [Related]
2. germline BRCA2 pathogenic variants in pediatric ganglioglioma: Case report and review of the literature.
Gupta A; Lechpammer M; Brossier NM
Childs Nerv Syst; 2024 May; 40(5):1609-1612. PubMed ID: 38168858
[TBL] [Abstract] [Full Text] [Related]
3. brca1/2 reversion mutations in a pan-cancer cohort.
Nakamura K; Hayashi H; Kawano R; Ishikawa M; Aimono E; Mizuno T; Kuroda H; Kojima Y; Niikura N; Kawanishi A; Takeshita K; Suzuki S; Ueno S; Okuwaki K; Sasaki J; Yamaguchi M; Masuda K; Chiyoda T; Yamagami W; Okada C; Nohara S; Tanishima S; Nishihara H
Cancer Sci; 2024 Feb; 115(2):635-647. PubMed ID: 38041241
[TBL] [Abstract] [Full Text] [Related]
4. The tumor Suppressor brca1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.
Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
[TBL] [Abstract] [Full Text] [Related]
5. ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
Liang Y; Ruan H; Yu M; Lü B
Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
[TBL] [Abstract] [Full Text] [Related]
6. Genomic Profiling Reveals germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar cell Carcinoma.
Mandelker D; Marra A; Zheng-Lin B; Selenica P; Blanco-Heredia J; Zhu Y; Gazzo A; Wong D; Yelskaya Z; Rai V; Somar J; Ostafi S; Mehta N; Yang C; Li Y; Brown DN; da Silva EM; Pei X; Linkov I; Terraf P; Misyura M; Ceyhan-Birsoy O; Ladanyi M; Berger M; Pareja F; Stadler Z; Offit K; Riaz N; Park W; Chou J; Capanu M; Koehler M; Rosen E; O'Reilly EM; Reis-Filho JS
J Clin Oncol; 2023 Nov; 41(33):5151-5162. PubMed ID: 37607324
[TBL] [Abstract] [Full Text] [Related]
7. Homologous Recombination Deficiency (HRD) in Cutaneous Oncology.
Akinjiyan FA; Morecroft R; Phillipps J; Adeyelu T; Elliott A; Park SJ; Butt OH; Zhou AY; Ansstas G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445949
[TBL] [Abstract] [Full Text] [Related]
8. Exceptional Response of Pancreatic Acinar cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a germline BRCA2 Variant.
Sunami T; Yamada A; Kondo T; Kanai M; Nagai K; Uchida Y; Yokode M; Matsumori T; Uza N; Murakami H; Yamada T; Muto M
Pancreas; 2022 Oct; 51(9):1258-1262. PubMed ID: 37078954
[TBL] [Abstract] [Full Text] [Related]
9. brca1/2 Pathogenic Variants Are Not Common in Merkel cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature.
Gaubert A; Kervarrec T; Montaudié H; Burel-Vandenbos F; Cardot-Leccia N; Di Mauro I; Fabas T; Tallet A; Kubiniek V; Pedeutour F; Dadone-Montaudié B
J Invest Dermatol; 2023 Jul; 143(7):1178-1186. PubMed ID: 36754117
[TBL] [Abstract] [Full Text] [Related]
10. The BRCAness Landscape of Cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
11. Dissection of transcriptome dysregulation and immune characterization in women with germline brca1 mutation at single-cell resolution.
Yu X; Lin W; Spirtos A; Wang Y; Chen H; Ye J; Parker J; Liu CC; Wang Y; Quinn G; Zhou F; Chambers SK; Lewis C; Lea J; Li B; Zheng W
BMC Med; 2022 Sep; 20(1):283. PubMed ID: 36076202
[TBL] [Abstract] [Full Text] [Related]
12. Pan-cancer analysis of the prognostic and immunological role of brca1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatic mixed acinar-neuroendocrine carcinoma in a patient with a germline BRCA2 mutation: a case report.
Ikeda M; Miura S; Kume K; Kikuta K; Hamada S; Takikawa T; Nakagawa K; Unno M; Furukawa T; Masamune A
Clin J Gastroenterol; 2022 Oct; 15(5):999-1005. PubMed ID: 35819745
[TBL] [Abstract] [Full Text] [Related]
14. brca1: An Endocrine and Metabolic Regulator.
Werner H
Front Endocrinol (Lausanne); 2022; 13():844575. PubMed ID: 35432218
[TBL] [Abstract] [Full Text] [Related]
15. Identification and Management of Pathogenic Variants in brca1, BRCA2, and PALB2 in a tumor-Only Genomic Testing Program.
Bychkovsky BL; Li T; Sotelo J; Tayob N; Mercado J; Gomy I; Chittenden A; Kane S; Stokes S; Hughes ME; Kim JS; Umeton R; Awad MM; Konstantinopoulos PA; Yurgelun MB; Wolpin BM; Taplin ME; Newmark RE; Johnson BE; Lindeman NI; MacConaill LE; Garber JE; Lin NU
Clin Cancer Res; 2022 Jun; 28(11):2349-2360. PubMed ID: 35363308
[TBL] [Abstract] [Full Text] [Related]
16. BAP1 tumor Predisposition Syndrome Presenting as a Recurrent ovarian Sex Cord-Stromal tumor.
Albright BB; Wignall E; Bentley RC; Havrilesky LJ; Previs RA; Strickland KC
Int J Gynecol Pathol; 2023 Jan; 42(1):83-88. PubMed ID: 35348477
[TBL] [Abstract] [Full Text] [Related]
17. Predicting the Likelihood of Carrying a
Ang BH; Ho WK; Wijaya E; Kwan PY; Ng PS; Yoon SY; Hasan SN; Lim JMC; Hassan T; Tai MC; Allen J; Lee A; Taib NAM; Yip CH; Hartman M; Lim SH; Tan EY; Tan BKT; Tan SM; Tan VKM; Ho PJ; Khng AJ; Dunning AM; Li J; Easton DF; Antoniou AC; Teo SH
J Clin Oncol; 2022 May; 40(14):1542-1551. PubMed ID: 35143328
[TBL] [Abstract] [Full Text] [Related]
18. Rare germline copy number variants (CNVs) and breast cancer risk.
Dennis J; Tyrer JP; Walker LC; Michailidou K; Dorling L; Bolla MK; Wang Q; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Freeman LEB; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Castelao JE; Chang-Claude J; Chenevix-Trench G; Clarke CL; ; Collée JM; ; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dossus L; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; García-Closas M; Giles GG; González-Neira A; Guénel P; Hahnen E; Haiman CA; Hall P; Hollestelle A; Hoppe R; Hopper JL; Howell A; ; ; Jager A; Jakubowska A; John EM; Johnson N; Jones ME; Jung A; Kaaks R; Keeman R; Khusnutdinova E; Kitahara CM; Ko YD; Kosma VM; Koutros S; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Lacey JV; Lambrechts D; Larson NL; Linet M; Ogrodniczak A; Mannermaa A; Manoukian S; Margolin S; Mavroudis D; Milne RL; Muranen TA; Murphy RA; Nevanlinna H; Olson JE; Olsson H; Park-Simon TW; Perou CM; Peterlongo P; Plaseska-Karanfilska D; Pylkäs K; Rennert G; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Shibli R; Smeets A; Soucy P; Southey MC; Swerdlow AJ; Tamimi RM; Taylor JA; Teras LR; Terry MB; Tomlinson I; Troester MA; Truong T; Vachon CM; Wendt C; Winqvist R; Wolk A; Yang XR; Zheng W; Ziogas A; Simard J; Dunning AM; Pharoah PDP; Easton DF
Commun Biol; 2022 Jan; 5(1):65. PubMed ID: 35042965
[TBL] [Abstract] [Full Text] [Related]
19. Human iPSC-derived fallopian tube organoids with brca1 mutation recapitulate early-stage carcinogenesis.
Yucer N; Ahdoot R; Workman MJ; Laperle AH; Recouvreux MS; Kurowski K; Naboulsi DJ; Liang V; Qu Y; Plummer JT; Gayther SA; Orsulic S; Karlan BY; Svendsen CN
Cell Rep; 2021 Dec; 37(13):110146. PubMed ID: 34965417
[TBL] [Abstract] [Full Text] [Related]
20. Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.
Gansmo LB; Sofiyeva N; Bjørnslett M; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
Sci Rep; 2021 Dec; 11(1):23463. PubMed ID: 34873230
[TBL] [Abstract] [Full Text] [Related]
[Next]
